ImmunityBio, Inc. (IBRX)

8.08 -0.11 (-1.34%) USD  |  NASDAQ  |  Sep 04, 16:00
8.08 0.00 (0.00%) After-Hours: 20:00
More

ImmunityBio SG&A Expense (TTM) : 172.60M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for IBRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 172.60M
March 31, 2026 163.12M
December 31, 2025 150.00M
September 30, 2025 153.00M
June 30, 2025 152.64M
March 31, 2025 159.55M
December 31, 2024 168.78M
September 30, 2024 160.16M
June 30, 2024 156.06M
March 31, 2024 138.83M
December 31, 2023 129.62M
September 30, 2023 122.72M
June 30, 2023 110.22M
March 31, 2023 94.78M
December 31, 2022 102.71M
September 30, 2022 104.40M
June 30, 2022 114.72M
March 31, 2022 130.59M
December 31, 2021 135.26M
September 30, 2021 118.00M
June 30, 2021 93.08M
March 31, 2021 67.16M
December 31, 2020 27.25M
September 30, 2020 20.72M
Date Value
June 30, 2020 20.03M
March 31, 2020 17.70M
December 31, 2019 18.06M
September 30, 2019 19.20M
June 30, 2019 24.75M
March 31, 2019 34.16M
December 31, 2018 42.72M
September 30, 2018 50.86M
June 30, 2018 54.66M
March 31, 2018 55.19M
December 31, 2017 57.12M
September 30, 2017 59.45M
June 30, 2017 70.49M
March 31, 2017 84.95M
December 31, 2016 95.39M
September 30, 2016 154.51M
June 30, 2016 168.94M
March 31, 2016 222.78M
December 31, 2015 199.48M
September 30, 2015 126.46M
June 30, 2015 88.54M
March 31, 2015 6.113M
December 31, 2014 2.745M
March 31, 2014 0.939M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Moderna, Inc. 965.00M
Sarepta Therapeutics, Inc. 436.74M
Arrowhead Pharmaceuticals, Inc. 172.57M
Oncolytics Biotech, Inc. 16.62M
Sangamo Therapeutics, Inc. 31.64M